Mural Oncology Files Proxy Statement for 2025 Annual Meeting
| Field | Detail |
|---|---|
| Company | Mural Oncology PLC |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Mural Oncology proxy filed. Vote on exec pay & board for 2025 meeting.
AI Summary
Mural Oncology plc filed its definitive proxy statement on April 28, 2025, for its annual meeting on June 11, 2025. The company, previously known as Mural Oncology Ltd and Pistachiovale Ltd, is incorporated in L2 and operates in the Pharmaceutical Preparations sector. The filing details executive compensation, board nominations, and other corporate governance matters for the fiscal year ending December 31, 2024.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed participation in corporate governance decisions.
Risk Assessment
Risk Level: low — This is a routine annual proxy filing and does not contain new material financial or operational information that would inherently increase risk.
Key Numbers
- 2024 — Fiscal Year End (The proxy statement covers corporate matters for the fiscal year ending December 31, 2024.)
Key Players & Entities
- Mural Oncology plc (company) — Registrant
- Mural Oncology Ltd (company) — Former company name
- Pistachiovale Ltd (company) — Former company name
- 20250428 (date) — Filing date
- 20250611 (date) — Meeting date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide shareholders with information for the annual meeting, including details on executive compensation, board nominations, and other corporate governance matters.
When is the annual meeting of Mural Oncology plc scheduled?
The annual meeting of Mural Oncology plc is scheduled for June 11, 2025.
What were Mural Oncology plc's former names?
Mural Oncology plc was formerly known as Mural Oncology Ltd and Pistachiovale Ltd.
What is Mural Oncology plc's industry classification?
Mural Oncology plc is classified under Pharmaceutical Preparations (SIC code 2834).
On what date was this definitive proxy statement filed?
This definitive proxy statement was filed on April 28, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Mural Oncology plc.